Director/PDMR Shareholding

RNS Number : 9644W

Venture Life Group PLC

29 December 2021

 

29 December 2021

VENTURE LIFE GROUP PLC

("Venture Life" "VLG" or the "Group")

Director Dealings

Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that on 24 December 2021 certain of the Company's Directors purchased shares as follow:

Name	No. of Shares Purchased	Price per share	Resultant holding post transaction (%)
Jerry Randall, Chief Executive Officer	100,000	30.15p	2,084,865 (1.7%)
Sharon Collins, Chief Commercial Officer	100,000	30.15p	1,209,977 (1.0%)
Gianluca Braguti, Chief Manufacturing Officer	100,000	30.15p	3,742,730 (3 .0 %)

For further information, please contact:

Venture Life Group PLC	[phone]
Jerry Randall, Chief Executive Officer Daniel Wells, Chief Financial Officer
Cenkos Securities plc (Nomad and Broker)	[phone]
Stephen Keys / Camilla Hume
Russell Kerr / Michael Johnson (Sales)
N+1 Singer (Joint Broker)	[phone]
Shaun Dobson / Alaina Wong (Corporate Finance)
Jonathan Dighe (Sales)

About Venture Life ( www.venture-life.com )

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, Italy, The Netherlands and Sweden, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. Its products are sold in over 90 countries worldwide.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners. 

Through its two Development & Manufacturing operations in Italy and Sweden, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jerry Randall
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Venture Life Group plc
b)	LEI	213800S8CZUPLAB2KC70
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 0.3p each in Venture Life Group plc GB00BFPM8908
b)	Nature of the transaction	Purchase of ordinary shares
c)	Price(s) and volume(s)	100,000 ordinary shares at 30.15 pence per share
d)	Aggregated information - Aggregated volume - Price	See above
e)	Date of the transaction	24 December 2021
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Sharon Collins
2	Reason for the notification
a)	Position/status	Chief Commercial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Venture Life Group plc
b)	LEI	213800S8CZUPLAB2KC70
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 0.3p each in Venture Life Group plc GB00BFPM8908
b)	Nature of the transaction	Purchase of ordinary shares
c)	Price(s) and volume(s)	100,000 ordinary shares at 30.15 pence per share
d)	Aggregated information - Aggregated volume - Price	See above
e)	Date of the transaction	24 December 2021
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Gianluca Braguti
2	Reason for the notification
a)	Position/status	Chief Manufacturing Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Venture Life Group plc
b)	LEI	213800S8CZUPLAB2KC70
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 0.3p each in Venture Life Group plc GB00BFPM8908
b)	Nature of the transaction	Purchase of ordinary shares
c)	Price(s) and volume(s)	100,000 ordinary shares at 30.15 pence per share
d)	Aggregated information - Aggregated volume - Price	See above
e)	Date of the transaction	24 December 2021
f)	Place of the transaction	London Stock Exchange

 

END

 

 

DSHFLFVFFFLAFIL